Pharmatusgrip 10 Sachets Powder for Oral Solution
This medicine is indicated for the symptomatic relief of colds and flu that present with pain, fever, nasal congestion and unproductive cough (irritative and nervous). For over 12 years
This medicine is indicated for the symptomatic relief of colds and flu that present with pain, fever, nasal congestion and unproductive cough (irritative and nervous). For over 12 years
Pharmatusgrip (10 Sachets Powder For Oral Solution)
PRECAUTIONS RELATING TO EXCIPIENTS
- This medicine contains sorbitol. Patients with hereditary [FRUCTOSE INTOLERANCE] should not take this medicine.
- This medicine contains amaranth as an excipient. May cause allergic-type reactions including [ASTHMA], especially in patients with [SALICYLATE ALLERGY].
- This medicine contains sucrose. Patients with hereditary [FRUCTOSE INTOLERANCE], glucose or galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine.
- This medicine contains sodium salts. To know the exact sodium content, it is recommended to review the composition. Oral and parenteral dosage forms with amounts of sodium greater than 1 mmol (23 mg) / maximum daily dose should be used with caution in patients with [ARTERIAL HYPERTENSION], [KIDNEY FAILURE] or with low sodium diets.
- This medicine contains sucrose. Its use in oral liquids and pharmaceutical forms that remain in contact with the mouth for a while can damage the teeth.
PREGNANCY
Animal safety : no data available.
Safety in humans : contraindicated in the first trimester of pregnancy since pseudoephedrine is contraindicated in the first trimester of pregnancy. Paracetamol and pseudoephedrine cross the placental barrier. The use of nasal decongestants during the first trimester of pregnancy has been associated with slightly increased risk of the appearance of three types of malformations: gastroschisis and atresia of the small intestine, vascular disruption, and hemifacial microsomy. The risk is higher in women who smoke.
Effects on Fertility : No specific studies have been performed in humans.
ADVERSE REACTIONS RELATING TO EXCIPIENTS
- Because it contains amaranth (E-123) it can cause [HYPERSENSITIVITY REACTIONS].
Doping
Pseudoephedrine is a prohibited substance during competition.
It is prohibited when its administration results in a urine concentration greater than 150 mcg / ml.
The detection in a sample during the competition of any quantity of pseudoephedrine in combination with a diuretic or a masking agent, will be considered an adverse analytical result, unless the athlete has obtained an approved therapeutic use authorization (TUE) for ephedrine, in addition than that granted for the diuretic or masking agent.
It is considered a “specific substance” and, therefore, a violation of the rule in which this substance is involved may lead to a reduction in the penalty as long as the athlete can demonstrate that the use of the specific substance in question was not intended to increase your athletic performance.
Package Leaflet Pharmatusgrip 10 Sachets Powder for Oral solution
- For further information on the nature of the review controls, as well as the possibility of contacting the author of the review please consult our Transparency Charter.
- No inducements have been provided for these reviews
- Reviews are published and kept for a period of five years
- Reviews can not be modified: If a customer wishes to modify their review then they can do so by contacting Verified Reviews directly to remove the existing review and publish an amended one
- The reasons for deletion of reviews are available here.